Stockholders' Equity

In 2009, the Company's stockholders approved the 2009 Incentive Plan (“2009 Plan”) and the reservation of 7.5 million shares of common stock for issuance thereunder, which was subsequently increased to 23.5 million shares. The 2009 Plan provides for the grant of incentive stock options, non-statutory stock options, restricted stock, restricted stock units, stock appreciation rights, performance units, and performance shares. The per share exercise price for shares to be issued pursuant to exercise of an option must be no less than 100% of the fair market value per share on the date of grant.

Upon approval of the 2009 Plan, all of the Company's other stock plans were terminated as to future grants. Although these plans have been terminated, they will continue to govern all awards granted under them until the expiration of the awards.

As of September 30, 2017, an aggregate of 10.2 million shares were authorized for future issuance under the Company's stock plans, of which 6.9 million of such shares were issuable upon exercise of outstanding options and delivery of shares upon vesting of restricted stock units and 3.3 million shares of common stock were available for future grant. Awards other than stock options and stock appreciation rights reduce common stock available for grant by 1.36 shares for every share of common stock subject to such an award. Awards under the 2009 plan that expire or are cancelled without delivery of shares generally become available for issuance under the plan.

Stock Repurchase Program

During the fourth quarter of 2017, the Board of Directors approved an additional $200.0 million stock repurchase plan. The timing of repurchases will depend upon capital needs to support the growth of the Company's business, market conditions and other factors. Although stock repurchases are intended to increase stockholder value, purchases of shares reduce the Company's liquidity. During 2017 and 2016, the Company repurchased 4.3 million shares and 6.8 million shares of its common stock for $159.7 million and $141.2 million (including commissions), respectively. As of September 30, 2017, $253.2 million remains available under repurchase programs authorized by the Board of Directors, inclusive of programs authorized by the Board of Directors prior to 2017.

In addition to the repurchases discussed above, the Company repurchased 549,000, 46,000 and 61,000 shares of its common stock during 2017, 2016, and 2015, respectively, in settlement of employee tax withholding obligations due upon the vesting of restricted stock units. The Company paid $17.3 million, $1.0 million and $1.5 million, respectively, in conjunction with these purchases.

Accumulated Other Comprehensive Income

Accumulated other comprehensive income, net of tax as applicable, consisted of the following:



	As of
	September 30, 2017			October 1, 2016
	(In thousands)
Foreign currency translation adjustments	$	90,952		$	90,364
Unrealized holding losses on derivative financial instruments	(212		)	(439		)
Unrecognized net actuarial loss and unrecognized transition cost for benefit plans	(13,946		)	(24,544		)
Total	$	76,794		$	65,381